ADVANCED LUNG CANCER
Clinical trials for ADVANCED LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breathe in hope: new mRNA vaccine targets lung tumors
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase study tests an inhaled mRNA vaccine called BMD006 for people with advanced lung cancer or solid tumors that have spread to the lungs. The vaccine is designed to train the immune system to attack tumor-related proteins. About 83 participants who have exhausted sta…
Matched conditions: ADVANCED LUNG CANCER
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 04:50 UTC
-
New hope for advanced lung cancer: experimental combo therapy enters human trials
Disease control Recruiting nowThis study tests a new drug called MHB036C, given with other anti-cancer treatments, for people with advanced lung cancer that has not responded to standard therapies. The goal is to find the safest dose and see if it shrinks tumors. About 300 adults aged 18-75 with good performa…
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 26, 2026 04:46 UTC
-
New drug aims to break Cancer's growth signals
Disease control Recruiting nowThis early-phase study tests a new drug called BBO-10203 in about 392 adults with advanced solid tumors (like breast, lung, or colorectal cancer) that have not responded to other treatments. The drug works by blocking a key cancer growth pathway. The main goals are to find the sa…
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE1 • Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New hope for advanced lung cancer: experimental drug TQB6411 enters trials
Disease control Recruiting nowThis study tests an experimental drug called TQB6411 in people with advanced lung cancer. The goal is to find the best dose and see if it can shrink tumors or slow the disease. About 465 participants will take part in this early-to-mid stage trial.
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New drug duo targets tough lung cancers in early trial
Disease control Recruiting nowThis study tests a combination of two experimental drugs, BNT324 and BNT327, in people with advanced lung cancer that has spread or come back. The goal is to see if the combination can shrink tumors and control the disease. About 594 adults with small cell or non-small cell lung …
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New telehealth program aims to ease daily struggles for advanced cancer patients
Symptom relief Recruiting nowThis study tests a telehealth program called ENGAGE for people with stage IV breast, prostate, lung, or colorectal cancer. The program helps manage symptoms like pain, fatigue, and distress that interfere with daily life. About 190 participants will be randomly assigned to ENGAGE…
Matched conditions: ADVANCED LUNG CANCER
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated May 26, 2026 04:48 UTC
-
New app aims to boost lung cancer survivors' strength and well-being
Symptom relief Recruiting nowThis study tests a mobile app called PROMOTE designed to help lung cancer survivors improve their physical function, manage breathlessness and sleep problems, and adopt healthier habits. Researchers will enroll 250 people with stage I-III lung cancer who are starting treatment ai…
Matched conditions: ADVANCED LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 04:38 UTC
-
New study tests app and nurse support to ease chemo side effects
Symptom relief Recruiting nowThis study tests whether a digital health platform, which includes a symptom-tracking app and a structured telenursing program, can help cancer patients better manage chemotherapy side effects and improve their quality of life. About 414 adults with early or advanced gastric, lun…
Matched conditions: ADVANCED LUNG CANCER
Phase: NA • Sponsor: Ulsan University Hospital • Aim: Symptom relief
Last updated May 26, 2026 04:35 UTC